SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001758
Filing Date
2024-01-19
Accepted
2024-01-19 17:20:42
Documents
14
Period of Report
2024-01-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20240118_8k.htm   iXBRL 8-K 36073
2 EXHIBIT 3.1 ex_616826.htm EX-3.1 11513
  Complete submission text file 0001437749-24-001758.txt   191221

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240118.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240118_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240118_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240118_pre.xml EX-101.PRE 12458
8 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240118_8k_htm.xml XML 2828
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 24546483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)